HK1006002A1 - Treatment of obesity - Google Patents
Treatment of obesityInfo
- Publication number
- HK1006002A1 HK1006002A1 HK98105187A HK98105187A HK1006002A1 HK 1006002 A1 HK1006002 A1 HK 1006002A1 HK 98105187 A HK98105187 A HK 98105187A HK 98105187 A HK98105187 A HK 98105187A HK 1006002 A1 HK1006002 A1 HK 1006002A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- obesity
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27724088A | 1988-11-29 | 1988-11-29 | |
PCT/GB1989/001383 WO1990006110A1 (fr) | 1988-11-29 | 1989-11-21 | Traitement de l'obesite |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1006002A1 true HK1006002A1 (en) | 1999-02-05 |
Family
ID=23060006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98105187A HK1006002A1 (en) | 1988-11-29 | 1998-06-11 | Treatment of obesity |
Country Status (16)
Country | Link |
---|---|
US (1) | US5436272A (fr) |
EP (1) | EP0397831B1 (fr) |
JP (1) | JPH06102622B2 (fr) |
KR (1) | KR0164435B1 (fr) |
AU (1) | AU633529B2 (fr) |
CA (1) | CA2003524C (fr) |
DE (2) | DE19975039I2 (fr) |
DK (1) | DK175587B1 (fr) |
HK (1) | HK1006002A1 (fr) |
IE (1) | IE61928B1 (fr) |
IL (1) | IL92406A (fr) |
LU (1) | LU90866I2 (fr) |
NL (1) | NL300066I2 (fr) |
PH (1) | PH26677A (fr) |
WO (1) | WO1990006110A1 (fr) |
ZA (1) | ZA899058B (fr) |
Families Citing this family (100)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8531071D0 (en) * | 1985-12-17 | 1986-01-29 | Boots Co Plc | Therapeutic compound |
WO1994000114A1 (fr) * | 1992-06-23 | 1994-01-06 | Sepracor Inc. | Procedes et compositions utilises pour traiter la depression et d'autres affections avec de la sibutramine (-) optiquement pure |
AU721924B2 (en) * | 1992-06-23 | 2000-07-20 | Sepracor, Inc. | Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine |
GB9301192D0 (en) | 1993-06-09 | 1993-06-09 | Trott Francis W | Flower shaped mechanised table |
US5459164A (en) * | 1994-02-03 | 1995-10-17 | Boots Pharmaceuticals, Inc. | Medical treatment |
DE19518988A1 (de) * | 1995-05-29 | 1996-12-05 | Basf Ag | Verwendung arylsubstituierter Cyclobutylalkylamine zur Behandlung der Fettleibigkeit |
GB9619757D0 (en) | 1996-09-21 | 1996-11-06 | Knoll Ag | Chemical process |
GB9619962D0 (en) * | 1996-09-25 | 1996-11-13 | Knoll Ag | Medical treatment |
GB9619961D0 (en) * | 1996-09-25 | 1996-11-13 | Knoll Ag | Medical treatment |
GB9727131D0 (en) | 1997-12-24 | 1998-02-25 | Knoll Ag | Therapeutic agents |
US6331571B1 (en) | 1998-08-24 | 2001-12-18 | Sepracor, Inc. | Methods of treating and preventing attention deficit disorders |
US6339106B1 (en) | 1999-08-11 | 2002-01-15 | Sepracor, Inc. | Methods and compositions for the treatment and prevention of sexual dysfunction |
US6974838B2 (en) | 1998-08-24 | 2005-12-13 | Sepracor Inc. | Methods of treating or preventing pain using sibutramine metabolites |
US6476078B2 (en) | 1999-08-11 | 2002-11-05 | Sepracor, Inc. | Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction |
US6046242A (en) * | 1998-11-27 | 2000-04-04 | Basf Aktiengesellschaft | Use of aryl-substituted cyclobutylalkylamines for treating urinary incontinence |
US6696495B2 (en) | 1998-12-02 | 2004-02-24 | Snowden Pharmaceuticals, Llc | Treatment of disorders secondary to organic impairments |
US6323242B1 (en) | 1998-12-02 | 2001-11-27 | Peter Sterling Mueller | Treatment of disorders secondary to organic impairments |
BG65170B1 (bg) * | 1999-03-17 | 2007-05-31 | Knoll Gmbh | Използване на n-заместени производни на 1-[1-(4-хлорофенил)циклобутил]-3-метилбутиламин за производство на лекарство за лечение на разстройства при храненето |
MXPA01009467A (es) * | 1999-03-19 | 2004-03-19 | Knoll Gmbh | Metodo para controlar el aumento de peso asociado con farmacos terapeuticos. |
US6803387B1 (en) * | 1999-03-19 | 2004-10-12 | Abbott Gmbh & Co. Kg | Treatment of neuropathic pain or fibromyalgia |
JP2002539252A (ja) * | 1999-03-19 | 2002-11-19 | クノール・ゲー・エム・ベー・ハー | 胆石の治療 |
CA2367268A1 (fr) * | 1999-03-19 | 2000-09-28 | Knoll Pharmaceutical Company | Perte de poids apres une grossesse |
AU3894600A (en) | 1999-03-19 | 2000-10-09 | Knoll Pharmaceutical Company | Method of treating sexual dysfunction |
WO2000056312A1 (fr) | 1999-03-19 | 2000-09-28 | Knoll Gmbh | Traitement de l'hypertension arterielle pulmonaire |
ES2244420T3 (es) * | 1999-03-19 | 2005-12-16 | ABBOTT GMBH & CO. KG | Utilizacion de la sibutramina o de uno de sus derivados para el tratamiento de los trastornos del sueño. |
NZ514016A (en) * | 1999-03-19 | 2001-09-28 | Knoll Gmbh | Treatment of osteoarthritis |
AU773188C (en) * | 1999-03-19 | 2006-01-05 | Abbott Gmbh & Co. Kg | Method of treating eating disorders |
US6552087B1 (en) | 1999-03-19 | 2003-04-22 | Abbott Gmbh & Co. Kg | Therapeutic agent comprising (+)-sibutramine |
AU3895300A (en) | 1999-03-19 | 2000-10-09 | Knoll Pharmaceutical Company | Treatment of chronic fatigue syndrome |
WO2000056311A1 (fr) * | 1999-03-19 | 2000-09-28 | Knoll Pharmaceutical Company | Regulation du metabolisme |
AU3899100A (en) | 1999-03-19 | 2000-10-09 | Knoll Pharmaceutical Company | Treatment of hyperactivity disorders |
WO2000056308A1 (fr) | 1999-03-19 | 2000-09-28 | Knoll Pharmaceutical Company | Prevention de maladies cardio-vasculaires |
US6365632B1 (en) | 1999-03-19 | 2002-04-02 | Knoll Pharmaceuticals Company | Treatment of orthostatic hypotension |
US6245782B1 (en) | 1999-05-17 | 2001-06-12 | Heartdrug Research L.L.C. | Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors |
US6399826B1 (en) | 1999-08-11 | 2002-06-04 | Sepracor Inc. | Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain |
GB9926251D0 (en) * | 1999-11-06 | 2000-01-12 | Knoll Ag | Pharmaceutical formulation |
GB0004003D0 (en) * | 2000-02-22 | 2000-04-12 | Knoll Ag | Therapeutic agents |
AU2001282913A1 (en) * | 2000-09-08 | 2002-03-22 | Eli Lilly And Company | A method of treating weight gain associated with atypical antipsychotic use |
FR2814678B1 (fr) † | 2000-10-04 | 2002-12-20 | Aventis Pharma Sa | Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite |
US20020091114A1 (en) | 2000-10-04 | 2002-07-11 | Odile Piot-Grosjean | Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesity |
WO2002083631A1 (fr) * | 2001-04-13 | 2002-10-24 | Sepracor Inc. | Procedes permettant la preparation de didesmethylsibutramine et d'autres derives de sibutramine |
US20030139386A1 (en) * | 2001-12-21 | 2003-07-24 | Sophie Cote | Pharmaceutical compositions based on azetidine derivatives |
NZ534757A (en) * | 2002-03-12 | 2006-07-28 | Merck & Co Inc | Substituted amides |
US7105526B2 (en) | 2002-06-28 | 2006-09-12 | Banyu Pharmaceuticals Co., Ltd. | Benzimidazole derivatives |
US20040122033A1 (en) * | 2002-12-10 | 2004-06-24 | Nargund Ravi P. | Combination therapy for the treatment of obesity |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
US20050131074A1 (en) * | 2003-08-04 | 2005-06-16 | Beckman Kristen M. | Methods for treating metabolic syndrome |
WO2005028438A1 (fr) | 2003-09-22 | 2005-03-31 | Banyu Pharmaceutical Co., Ltd. | Nouveau derive de piperidine |
EP2305352A1 (fr) | 2004-04-02 | 2011-04-06 | Merck Sharp & Dohme Corp. | Inhibiteurs de la 5-alpha-reductase pour le traitement d'hommes aux troubles métaboliques et anthropométriques |
US7432398B2 (en) | 2005-01-06 | 2008-10-07 | Cj Corporation | Inorganic acid salts of sibutramine |
US7737155B2 (en) | 2005-05-17 | 2010-06-15 | Schering Corporation | Nitrogen-containing heterocyclic compounds and methods of use thereof |
ES2574014T3 (es) | 2005-05-30 | 2016-06-14 | Msd K.K. | Derivado de piperidina novedoso |
EP1916239A4 (fr) | 2005-08-10 | 2009-10-21 | Banyu Pharma Co Ltd | Composé de pyridone |
EP1921065B1 (fr) | 2005-08-24 | 2010-10-20 | Banyu Pharmaceutical Co., Ltd. | Dérivé phénylpyridone |
WO2007029847A1 (fr) | 2005-09-07 | 2007-03-15 | Banyu Pharmaceutical Co., Ltd. | Dérivé de pyridone substitué aromatique bicylique |
WO2007034910A1 (fr) * | 2005-09-22 | 2007-03-29 | Eisai R & D Management Co., Ltd. | Préparation thérapeutique pour le traitement de la boulimie et de la dépression associée à la boulimie |
EP1940842B1 (fr) | 2005-09-29 | 2012-05-30 | Merck Sharp & Dohme Corp. | Dérivés acylés de spiropipéridine en tant que modulateurs du récepteur de la mélanocortine-4 |
US8911751B2 (en) * | 2005-10-11 | 2014-12-16 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Compositions for nasal delivery |
BRPI0617621A2 (pt) | 2005-10-21 | 2011-08-02 | Novartis Ag | combinação de compostos orgánicos |
AU2006307046A1 (en) | 2005-10-27 | 2007-05-03 | Msd K.K. | Novel benzoxathiin derivative |
MY146564A (en) | 2005-11-10 | 2012-08-30 | Msd Kk | Aza-substituted spiro derivatives |
RU2455981C2 (ru) * | 2006-06-16 | 2012-07-20 | Теракос, Инк. | Лечение ожирения антагонистами мускаринового рецептора м1 |
US8748419B2 (en) | 2006-06-16 | 2014-06-10 | Theracos, Inc. | Treating obesity with muscarinic receptor M1 antagonists |
MX2009002282A (es) | 2006-09-07 | 2009-03-20 | Nycomed Gmbh | Tratamiento de combinacion para diabetes mellitius. |
EP2066329B1 (fr) * | 2006-09-15 | 2017-09-06 | Reviva Pharmaceuticals, Inc. | Synthèse, utilisation et compositions de cyclobutylméthylamines |
US8604244B2 (en) | 2010-07-02 | 2013-12-10 | Reviva Pharmaceuticals, Inc. | Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives |
EP2698157B1 (fr) | 2006-09-22 | 2015-05-20 | Merck Sharp & Dohme Corp. | Procédé de traitement utilisant des inhibiteurs de synthèse d'acide gras |
WO2008038692A1 (fr) | 2006-09-28 | 2008-04-03 | Banyu Pharmaceutical Co., Ltd. | dÉrivÉ de diarylcÉtimine |
US20080249156A1 (en) * | 2007-04-09 | 2008-10-09 | Palepu Nageswara R | Combinations of statins and anti-obesity agent and glitazones |
CN101795684A (zh) * | 2007-04-09 | 2010-08-04 | 赛多斯有限责任公司 | 他汀类化合物与抗肥胖药的组合 |
CA2963857A1 (fr) | 2007-06-04 | 2008-12-11 | Ben-Gurion University Of The Negev Research And Development Authority | Composes triaryles et compositions les comprenant |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
US7879802B2 (en) | 2007-06-04 | 2011-02-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
CA2714617A1 (fr) | 2008-03-06 | 2009-09-11 | Banyu Pharmaceutical Co., Ltd. | Derive d'alkylaminopyridine |
US20110015198A1 (en) | 2008-03-28 | 2011-01-20 | Banyu Pharmaceutical Co., Inc. | Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism |
EP3239170B1 (fr) | 2008-06-04 | 2019-03-20 | Synergy Pharmaceuticals Inc. | Agonistes de guanylate cyclase utile dans le traitement de troubles gastro-intestinaux, d'une inflammation, d'un cancer et d'autres troubles |
EP2301936A1 (fr) | 2008-06-19 | 2011-03-30 | Banyu Pharmaceutical Co., Ltd. | Dérivé de spirodiamine-diarylcétoxime |
EP3241839B1 (fr) | 2008-07-16 | 2019-09-04 | Bausch Health Ireland Limited | Agonistes de guanylate cyclase utiles pour le traitement de troubles gastro-intestinaux, inflammatoires, cancéreux et autres |
EP2319841A1 (fr) | 2008-07-30 | 2011-05-11 | Msd K.K. | Dérivé de cycloalkylamine à noyaux fusionnés à (5 chaînons)-(5 chaînons) ou (5 chaînons) (6 chaînons) |
CA2741125A1 (fr) | 2008-10-22 | 2010-04-29 | Merck Sharp & Dohme Corp. | Nouveaux derives de benzimidazole cycliques utiles comme agents anti-diabetiques |
WO2010051206A1 (fr) | 2008-10-31 | 2010-05-06 | Merck Sharp & Dohme Corp. | Nouveaux agents antidiabétiques utiles avec des dérivés de benzimidazole cycliques |
WO2010065889A2 (fr) * | 2008-12-06 | 2010-06-10 | Auspex Pharmaceutical | Inhibiteurs cyclobutaneméthanamine de la réabsorption de monoamine |
US20110243940A1 (en) | 2008-12-16 | 2011-10-06 | Schering Corporation | Bicyclic pyranone derivatives and methods of use thereof |
EP2379547A1 (fr) | 2008-12-16 | 2011-10-26 | Schering Corporation | Dérivés de pyridopyrimidine et leurs procédés d'utilisation |
US8895596B2 (en) | 2010-02-25 | 2014-11-25 | Merck Sharp & Dohme Corp | Cyclic benzimidazole derivatives useful as anti-diabetic agents |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
EP2677869B1 (fr) | 2011-02-25 | 2017-11-08 | Merck Sharp & Dohme Corp. | Nouveaux dérivés d'azabenzimidazole cyclique utiles en tant qu'agents antidiabétiques |
AU2013296470B2 (en) | 2012-08-02 | 2016-03-17 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
AU2014219020A1 (en) | 2013-02-22 | 2015-07-23 | Merck Sharp & Dohme Corp. | Antidiabetic bicyclic compounds |
WO2014139388A1 (fr) | 2013-03-14 | 2014-09-18 | Merck Sharp & Dohme Corp. | Nouveaux dérivés d'indole utiles en tant qu'agents antidiabétiques |
US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
CA2905435A1 (fr) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions utiles pour le traitement de troubles gastro-intestinaux |
JP6606491B2 (ja) | 2013-06-05 | 2019-11-13 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法 |
WO2015051496A1 (fr) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Composés tricycliques antidiabétiques |
JP6657101B2 (ja) | 2013-11-05 | 2020-03-04 | ベン グリオン ユニバーシティ オブ ザ ネガフ リサーチ アンド ディベロップメント オーソリティ | 糖尿病及びそれから生じる疾患合併症の治療のための化合物 |
JP6769963B2 (ja) | 2014-08-29 | 2020-10-14 | ティエエッセ ファルマ ソチエタ レスポンサビリタ リミタータ | α−アミノ−β−カルボキシムコン酸セミアルデヒド脱炭酸酵素の阻害剤 |
AU2017342083A1 (en) | 2016-10-14 | 2019-04-11 | Tes Pharma S.R.L. | Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase |
EP3551176A4 (fr) | 2016-12-06 | 2020-06-24 | Merck Sharp & Dohme Corp. | Composés hétérocycliques antidiabétiques |
EP3558298A4 (fr) | 2016-12-20 | 2020-08-05 | Merck Sharp & Dohme Corp. | Composés de spirochromane antidiabétiques |
KR20210111248A (ko) | 2018-11-20 | 2021-09-10 | 테스 파마 에스.알.엘. | α-아미노-β-카르복시뮤콘산 세미알데하이드 데카르복실라제의 저해제 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA821577B (en) * | 1981-04-06 | 1983-03-30 | Boots Co Plc | Therapeutic agents |
US4443449A (en) * | 1981-04-06 | 1984-04-17 | The Boots Company Limited | Arylcyclobutylalkylamines and anti-depression composition and methods using same |
GB2184122B (en) * | 1985-12-17 | 1989-10-18 | Boots Co Plc | N,n-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methyl butylamine hydrochloride monohydrate |
GB8704777D0 (en) * | 1987-02-28 | 1987-04-01 | Boots Co Plc | Medical treatment |
-
1989
- 1989-11-17 IE IE369089A patent/IE61928B1/en not_active IP Right Cessation
- 1989-11-21 CA CA002003524A patent/CA2003524C/fr not_active Expired - Lifetime
- 1989-11-21 KR KR1019900701628A patent/KR0164435B1/ko not_active IP Right Cessation
- 1989-11-21 EP EP89912801A patent/EP0397831B1/fr not_active Expired - Lifetime
- 1989-11-21 AU AU46207/89A patent/AU633529B2/en not_active Expired
- 1989-11-21 WO PCT/GB1989/001383 patent/WO1990006110A1/fr active IP Right Grant
- 1989-11-21 JP JP2500580A patent/JPH06102622B2/ja not_active Expired - Lifetime
- 1989-11-21 DE DE1999175039 patent/DE19975039I2/de active Active
- 1989-11-21 DE DE89912801T patent/DE68909219T2/de not_active Expired - Lifetime
- 1989-11-22 IL IL9240689A patent/IL92406A/en active Protection Beyond IP Right Term
- 1989-11-24 PH PH39593A patent/PH26677A/en unknown
- 1989-11-28 ZA ZA899058A patent/ZA899058B/xx unknown
-
1990
- 1990-07-26 DK DK199001776A patent/DK175587B1/da not_active IP Right Cessation
-
1992
- 1992-10-15 US US07/962,175 patent/US5436272A/en not_active Expired - Lifetime
-
1998
- 1998-06-11 HK HK98105187A patent/HK1006002A1/xx not_active IP Right Cessation
-
2001
- 2001-10-04 NL NL300066C patent/NL300066I2/nl unknown
- 2001-12-18 LU LU90866C patent/LU90866I2/fr unknown
Also Published As
Publication number | Publication date |
---|---|
AU633529B2 (en) | 1993-02-04 |
DE68909219D1 (de) | 1993-10-21 |
DE68909219T2 (de) | 1994-01-13 |
JPH02503682A (ja) | 1990-11-01 |
NL300066I2 (nl) | 2002-06-03 |
CA2003524A1 (fr) | 1990-05-29 |
CA2003524C (fr) | 1999-10-19 |
US5436272A (en) | 1995-07-25 |
WO1990006110A1 (fr) | 1990-06-14 |
IE61928B1 (en) | 1994-11-30 |
KR900701261A (ko) | 1990-12-01 |
ZA899058B (en) | 1990-08-29 |
IL92406A (en) | 1995-07-31 |
EP0397831A1 (fr) | 1990-11-22 |
KR0164435B1 (ko) | 1999-01-15 |
DE19975039I2 (de) | 2000-03-30 |
DK177690A (da) | 1990-09-13 |
DK177690D0 (da) | 1990-07-26 |
EP0397831B1 (fr) | 1993-09-15 |
PH26677A (en) | 1992-09-15 |
NL300066I1 (nl) | 2001-12-01 |
DK175587B1 (da) | 2004-12-13 |
JPH06102622B2 (ja) | 1994-12-14 |
AU4620789A (en) | 1990-06-26 |
LU90866I2 (fr) | 2002-02-18 |
IE893690L (en) | 1990-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1006002A1 (en) | Treatment of obesity | |
EP0350279A3 (en) | Treatment of water | |
GB2223959B (en) | Treatment of nitrophenolic by-products | |
GB2219503B (en) | Treatment of arthritis | |
AR243138A1 (es) | Procedimiento para el tratamiento de un efluente acuoso. | |
GB8809205D0 (en) | Treatment of oedema | |
GB8810748D0 (en) | Novel treatment | |
GB2220652B (en) | Treatment of pastures | |
GB8828679D0 (en) | Novel treatment | |
GB8816505D0 (en) | Novel treatment | |
GB8826819D0 (en) | Treatment of sewage | |
GB8827043D0 (en) | Treatment of materials | |
ZA899215B (en) | Treatment of water | |
ZA897787B (en) | Treatment of grain | |
GB8805885D0 (en) | Treatment of onions | |
IE880666L (en) | Compounds and treatment | |
GB8806481D0 (en) | Treatment of ulcers | |
IE880120L (en) | Novel treatment | |
GB8802254D0 (en) | Novel treatment | |
GB8816506D0 (en) | Novel treatment | |
GB8819576D0 (en) | Novel treatment | |
GB8819577D0 (en) | Novel treatment | |
GB8820102D0 (en) | Novel treatment | |
GB8826569D0 (en) | Novel treatment | |
GB8808033D0 (en) | Novel treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Change of ownership |
Owner name: ABBOTT GMBH & CO. KG Free format text: FORMER OWNER(S): ABBOTT GMBH Owner name: KNOLL GMBH Free format text: FORMER OWNER(S): KNOLL AKTIENGESELLSCHAFT Owner name: ABBOTT GMBH Free format text: FORMER OWNER(S): KNOLL GMBH |
|
AS | Change of ownership |
Owner name: ABBOTT GMBH Free format text: FORMER OWNER(S): KNOLL GMBH Owner name: KNOLL GMBH Free format text: FORMER OWNER(S): KNOLL AG Owner name: ABBOTT GMBH & CO. KG Free format text: FORMER OWNER(S): ABBOTT GMBH |
|
PF | Patent in force | ||
PE | Patent expired |
Effective date: 20091120 |